Program overview
Context
Indication: Multiple Myeloma
Mechanism: Unknown
Modality: Unknown
Sponsor: Hackensack Meridian Health
Selinexor 60 MG is flagged as registry stop signal because public records show a registry stop signal, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Multiple Myeloma
Mechanism: Unknown
Modality: Unknown
Sponsor: Hackensack Meridian Health
Registry: 4/5
Timeline: 0/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 3/5
https://clinicaltrials.gov/study/NCT04661137
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT04661137 | Registry Stop Signal (SUSPENDED) | None | Low Signal | rare_population_signal | strict_eligibility_signal |